Sanara MedTech Inc. — Director's Dealing 2019

Mar 22, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2019-03-15

Reporting Person: CGI Cellerate RX, LLC (10% Owner)
Reporting Person: Catalyst Rochal, LLC (10% Owner)
Reporting Person: Gurasich Bradley J. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series F Convertible Preferred Stock	$		Common Stock (227363000)		Direct
5% Convertible Promissory Note	$0.09	2021-03-01	Common Stock (16959339)		Direct

Footnotes

F1: Reflects 1,136,815 shares of Series F Convertible Preferred Stock ("Convertible <0x200E>Preferred Stock") owned of record by CGI Cellerate RX, LLC that are immediately convertible into 237,363,000 shares of Common Stock with equivalent <0x200E>voting rights. The Convertible Preferred Stock is convertible at any time, at the holder's election and has no expiration date. CGI Cellerate RX, LLC is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virtue of these relationships, CGI Cellerate RX, LLC, Catalyst Rochal, LLC and, Mr. Gurasich may be deemed to share voting and dispositive control over the Common Stock issuable upon the conversion of the Convertible Preferred Stock. Catalyst Rochal, LLC and Mr. Gurasich disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein.

F2: The Convertible Preferred Stock is convertible at on a 200 for 1 basis into fully paid and nonassessable shares of the Issuer's Common Stock.

F3: Reflects a $1,500,000.00 Convertible Promissory Note ("Note") from Wound Management Technologies, Inc. ("Issuer") to CGI Cellerate RX, LLC convertible into 16,959,339 shares of common stock of the Issuer at $0.09 per share as of December 31, 2018. CGI Cellerate RX, LLC is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virtue of these relationships, CGI Cellerate RX, LLC, Catalyst Rochal, LLC and, Mr. Gurasich may be deemed to share voting and dispositive control over the Common Stock issuable upon the conversion of the Note. Catalyst Rochal, LLC and Mr. Gurasich disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein.